Renal SABR: Implementation of A New Standard of Care
Details
Publication Year 2026-05-01,Volume 125,Issue #1,Page 123-135
Journal Title
International Journal of Radiation Oncology, Biology, Physics
Publication Type
Review
Abstract
SABR , or stereotactic ablative radiation therapy, has emerged as a new standard of care treatment option for localized renal cell carcinoma. Here, we present an accessible, high-yield guide to implementing SABR therapy for renal cell carcinoma. A question-and-answer format was selected for ease of navigation. Common queries around treatment indications and patient selection for SABR planning, delivery, and follow-up are addressed. Succinct, quick-hit answers are supported by relevant, contemporary literature.
Publisher
Elsevier
Keywords
Humans; *Kidney Neoplasms/surgery/radiotherapy/pathology/diagnostic imaging; *Radiosurgery/methods/standards; *Carcinoma, Renal Cell/surgery/pathology/radiotherapy/diagnostic imaging; *Standard of Care; Patient Selection
Department(s)
Radiation Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-01-20 12:06:14
Last Modified: 2026-04-28 11:42:13
An error has occurred. This application may no longer respond until reloaded. Reload 🗙